PAB
Click for more information
0.00% 0.7¢ patrys limited

Litigation, page-5

  1. attaman123
    154 Posts.
    lightbulb Created with Sketch. 54
    clock Created with Sketch.
    02/06/18
    18:02
    Post #: 33453193
    "Funds raised will be used to accelerate the development of Patrys’ Deoxymab platform, with a range of new pre‐clinical studies planned to create shareholder value by supporting business development efforts, as well as corporate activities including insurance claim prosecution."
    PAB Price at posting: 5.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

GNX NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project
right-arrow Created with Sketch.
MCT Metalicity looking for offers on Admiral Bay zinc project
right-arrow Created with Sketch.
IMR Imricor raises $35M to pursue growth and expansion into Australia and NZ
right-arrow Created with Sketch.
FMG Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%
right-arrow Created with Sketch.
PEC Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil
right-arrow Created with Sketch.
1CG One Click Group surpasses $3M in revenue YTD with 40% growth
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.7¢ 		Change
0.000(0.00%) 		Mkt cap ! $14.40M
Open High Low Value Volume
0.7¢ 0.7¢ 0.7¢ $1.4K 200K

Buyers (Bids)

No. Vol. Price($)
2 1074999 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
0.8¢ 1379932 3
View Market Depth
Last trade - 10.06am 25/07/2024 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.